135 related articles for article (PubMed ID: 10971742)
21. Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells.
Hadrup SR; Braendstrup O; Jacobsen GK; Mortensen S; Pedersen LØ; Seremet T; Andersen MH; Becker JC; Straten PT
Int J Cancer; 2006 Aug; 119(4):831-8. PubMed ID: 16557580
[TBL] [Abstract][Full Text] [Related]
22. [Atypical seminiferous tubules].
Peltier E; Viellefond A
Ann Pathol; 1994; 14(4):253-4. PubMed ID: 7916754
[No Abstract] [Full Text] [Related]
23. Carcinoma in situ and seminoma in equine testis.
Veeramachaneni DN; Sawyer HR
APMIS; 1998 Jan; 106(1):183-5; discussion 185-6. PubMed ID: 9524577
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cells.
Nettersheim D; Westernströer B; Haas N; Leinhaas A; Brüstle O; Schlatt S; Schorle H
Genes Chromosomes Cancer; 2012 Jul; 51(7):717-26. PubMed ID: 22489004
[TBL] [Abstract][Full Text] [Related]
25. Hanging drop cultures of human testis and testis cancer samples: a model used to investigate activin treatment effects in a preserved niche.
Jørgensen A; Young J; Nielsen JE; Joensen UN; Toft BG; Rajpert-De Meyts E; Loveland KL
Br J Cancer; 2014 May; 110(10):2604-14. PubMed ID: 24781282
[TBL] [Abstract][Full Text] [Related]
26. Immunocompetence in non-seminomatous testicular cancer patients before any treatment and one year after completion of therapy.
Kastelan Z; Pasini J; Derezić D; Lukac J; Kusić Z; Mrazovac D; Sosić H; Kastelan M
Anticancer Res; 2004; 24(5B):3251-5. PubMed ID: 15510619
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the autoimmune response in an 'in situ' carcinoma of the testis.
Lehmann D; Müller H
Int J Androl; 1987 Feb; 10(1):163-8. PubMed ID: 3294604
[TBL] [Abstract][Full Text] [Related]
28. Impact of localized radiotherapy on blood immune cells counts and function in humans.
Belka C; Ottinger H; Kreuzfelder E; Weinmann M; Lindemann M; Lepple-Wienhues A; Budach W; Grosse-Wilde H; Bamberg M
Radiother Oncol; 1999 Feb; 50(2):199-204. PubMed ID: 10368044
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours.
Andrews PW; Casper J; Damjanov I; Duggan-Keen M; Giwercman A; Hata J; von Keitz A; Looijenga LH; Millán JL; Oosterhuis JW; Pera M; Sawada M; Schmoll HJ; Skakkebaek NE; van Putten W; Stern P
Int J Cancer; 1996 Jun; 66(6):806-16. PubMed ID: 8647654
[TBL] [Abstract][Full Text] [Related]
30. [A combination of spermatocytic and classic seminoma, mature teratoma and carcinoma in situ of the testis. An attempt at an etiologic explanation].
Böhm E; Walz PH; Tan KH
Zentralbl Pathol; 1993 Aug; 139(3):255-60. PubMed ID: 8218126
[TBL] [Abstract][Full Text] [Related]
31. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of the tumour infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance.
Parker C; Milosevic M; Panzarella T; Banerjee D; Jewett M; Catton C; Tew-George B; Gospodarowicz M; Warde P
Eur J Cancer; 2002 Oct; 38(15):2014-9. PubMed ID: 12376206
[TBL] [Abstract][Full Text] [Related]
33. Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue.
Yuasa T; Okamoto K; Kawakami T; Mishina M; Ogawa O; Okada Y
J Urol; 2001 May; 165(5):1790-4. PubMed ID: 11342977
[TBL] [Abstract][Full Text] [Related]
34. Seminomas of the canine testis. Counterpart of spermatocytic seminoma of men?
Looijenga LH; Olie RA; van der Gaag I; van Sluijs FJ; Matoska J; Ploem-Zaaijer J; Knepflé C; Oosterhuis JW
Lab Invest; 1994 Oct; 71(4):490-6. PubMed ID: 7967505
[TBL] [Abstract][Full Text] [Related]
35. Glial cell line-derived neurotrophic factor promotes invasive behaviour in testicular seminoma cells.
Ferranti F; Muciaccia B; Ricci G; Dovere L; Canipari R; Magliocca F; Stefanini M; Catizone A; Vicini E
Int J Androl; 2012 Oct; 35(5):758-68. PubMed ID: 22519471
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis: a key effector mechanism of lymphocyte action in human nonseminomatous testicular carcinoma?
Schmelz HU; Port M; Hauck EW; Schwerer MJ; Weidner W; Sparwasser C; Abend M
BJU Int; 2005 Jul; 96(1):158-63. PubMed ID: 15963141
[TBL] [Abstract][Full Text] [Related]
37. Tumour responding accessory cells in testicular seminoma: an immunohistochemical study.
Cope NJ; McCullagh P; Sarsfield PT
Histopathology; 1999 Jun; 34(6):510-6. PubMed ID: 10383695
[TBL] [Abstract][Full Text] [Related]
38. Loss of Fhit expression in testicular germ cell tumors and intratubular germ cell neoplasia.
Eyzaguirre E; Gatalica Z
Mod Pathol; 2002 Oct; 15(10):1068-72. PubMed ID: 12379753
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of different apoptosis detection methods in human testicular cancer.
Schmelz HU; Abend M; Port M; Schwerer M; Hauck EW; Weidner W; Sparwasser C
Urol Res; 2004 Oct; 32(5):332-7. PubMed ID: 15118852
[TBL] [Abstract][Full Text] [Related]
40. Regenerating I messenger RNA and protein expression in the failing human testis: a potential molecular prognostic marker of seminoma.
Mauro V; Volle DH; Chevallier D; Haudebourg J; Sénégas-Balas F; Pointis G
Hum Pathol; 2011 Dec; 42(12):1841-8. PubMed ID: 21683984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
